| Date | Action | Shares | Price | Value | Owned After |
|---|---|---|---|---|---|
| Jan 2, 2026 | Sell(S) | 297 | $6.88 | $2K | 13K |
| Dec 31, 2025 | Option exercise(M) | 1K | — | $0 | 13K |
| Nov 18, 2025 | Grant(A) | 1K | $2.31 | $2K | 12K |
| Date | Action | Shares | Price | Value | Owned After |
|---|---|---|---|---|---|
| Dec 31, 2025 | Option exercise(M) | 1K | — | $0 | 0 |
Parsed from a single SEC EDGAR Form 4 filing (accession 0002037968-26-000002) within minutes of acceptance. Every field above traces to the original document. Verify it directly:
Connected pages for Athira Pharma, Inc.
This filing is the Follow view. The Build view lets your agent pull every Form 4 for the issuer, the net open-market picture over 90 days, and the accession behind each row, through REST or MCP.
curl -H "Authorization: Bearer YOUR_API_KEY" \ "https://arkolith.com/api/v1/filing/0002037968-26-000002"
Use Arkolith to summarize insider buying and selling at Athira Pharma, Inc. over the last 90 days and cite the filings.